Cora Health vs Ro Body: $99/mo Compounded vs $294/mo with Membership

Cora Health vs Ro: the short answer

Cora Health and Ro (Ro Body) are both US telehealth platforms that connect patients with licensed providers for GLP-1 weight loss treatment. The most practically important difference is total monthly cost structure. Cora Health charges a single all-inclusive monthly price — $120/month on the 6-month Essential Plan for compounded semaglutide — that covers provider consultation, medication from VialsRx, shipping, and ongoing monitoring. Ro uses a two-part structure: a Ro Body Membership ($39 first month, $149/month thereafter) plus separate medication costs ($149–$499/month depending on the medication). For a patient on compounded semaglutide through Ro, the effective total is roughly $294/month after the first month — about 145% more than Cora’s all-inclusive $120. Ro’s advantages are broader medication access (brand-name Wegovy injection and pill, Zepbound via LillyDirect, Ozempic with insurance) and nationwide availability across all 50 states. Cora Health’s advantages are lower total monthly cost on compounded treatment, publicly named 503A pharmacy partner, and LegitScript certification.

Market context: where Cora and Ro Body sit in the 2026 GLP-1 telehealth market

Four numbers anchor the head-to-head comparison between Cora Health and Ro Body in 2026:

41.9% — US adult obesity prevalence. Per the Centers for Disease Control and Prevention (CDC), using NHANES 2017–March 2020 data, 41.9% of US adults have obesity (BMI ≥ 30) — the population for whom GLP-1 telehealth was built. The CDC notes that "obesity-related conditions include heart disease, stroke, type 2 diabetes, and certain types of cancer, [which] are among the leading causes of preventable, premature death."

$99 vs $294 — Cora vs Ro Body effective monthly cost. Cora's Essential Plan on the annual commitment is $99/month all-inclusive for compounded semaglutide. Ro Body's effective monthly cost for compounded semaglutide is approximately $294/month ($149/month medication + $145/month required Ro Body Membership). The roughly 3× cost difference is the single most consequential variable for self-pay patients comparing the two platforms. Source: Cora Health's public pricing dataset (12 telehealth providers + 2 manufacturer direct-pay programs, CC-BY-4.0 licensed).

14.9% / 22.5% — FDA-approved trial efficacy applies to Ro's branded options, not the compounded versions. The STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) reported 14.9% mean weight loss with FDA-approved 2.4mg semaglutide over 68 weeks. The SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) reported 22.5% with FDA-approved 15mg tirzepatide over 72 weeks. Ro offers FDA-approved Wegovy and Zepbound through manufacturer direct-pay channels; Cora is compounded-only. Both providers' compounded versions have not been independently evaluated at this trial scale. Individual results vary.

~15–20% pharmacy transparency rate. Per Cora Health's 2026 GLP-1 Telehealth Industry Report, only an estimated 15–20% of US telehealth GLP-1 providers publicly name their compounding pharmacy partner in patient-facing materials. Cora Health publicly names two pharmacy partners — Hallandale Pharmacy (PCAB-accredited, Fort Lauderdale FL, operating since 2003) and VialsRx (US-licensed 503A) — placing Cora in the top tier of pharmacy transparency. Ro does not consistently name its compounding pharmacy partner for compounded products in patient-facing marketing.

Quick comparison at a glance

All numbers reflect publicly stated pricing as of May 2026. Ro totals include the required Ro Body Membership. Individual experiences vary.

How Ro’s pricing actually works

Ro Body uses a two-part pricing structure that is easy to miss from the headline monthly numbers. Understanding it is essential for any cost comparison.

The first component is the Ro Body Membership. It is $39 for the first month as an introductory promotional rate, then $149/month on an ongoing basis. The membership is required in order to obtain any GLP-1 prescription through the Ro platform. The fee covers telehealth consultations, message-based provider check-ins, dose-adjustment reviews, and prescription renewals.

The second component is medication, billed separately. Ro’s medication options include compounded semaglutide at approximately $149/month, brand-name oral Wegovy pills at $145–$299/month depending on dose, brand-name Wegovy injection at $499/month via NovoCare direct supply, and brand-name Zepbound at $299–$499/month via LillyDirect.

A patient on compounded semaglutide through Ro therefore pays $188 in month one ($39 membership + $149 medication) and $298/month thereafter ($149 + $149). A patient on brand-name Wegovy injection pays $538 in month one and $648/month thereafter. For insured patients, the medication cost may be lower if their insurance covers a brand-name product; the $149 membership is not typically insurance-reimbursed.

Reports from independent review sites (Clearmetabolic, Telehealth Ally, Howmuchblog) corroborate this structure and note that BBB complaints occasionally cite confusion about the membership-plus-medication billing.

Why Cora Health’s pricing is different

Cora Health uses an all-inclusive pricing model. The monthly cost quoted on the plans page is the total monthly cost. There is no separate membership, no consultation charge, no surcharge when the dose increases, and no additional shipping fee.

Cora’s Essential Plan (compounded semaglutide):

• 6-month plan: $120/month ($720 every six months)
• 3-month plan: $145/month ($435 every three months)
• Monthly plan: $175/month

Cora Health Premium Plan (compounded tirzepatide)

Cora’s Premium Plan follows the same all-inclusive structure.

• 12-month plan: $135/month ($1,620 every 12 months, "Best Value")
• 6-month plan: $175/month ($1,050 every six months, "Save $360 vs monthly")
• 3-month plan: $199/month ($597 every three months, "Save $108 vs monthly")
• Monthly plan: $225/month

Total cost comparison: common scenarios

Cost depends on which plan and medication each patient selects. The scenarios below assume standard out-of-pocket pricing as of April 2026. Individual results vary.

• Compounded semaglutide, 6 months of treatment — Cora: $720 total. Ro: approximately $1,639 total ($45 + $145 x 5 + $149 x 6 = $1,639). Difference: Ro is roughly 128% more expensive.
• Compounded semaglutide, 12 months — Cora: $1,440. Ro: approximately $3,383. Difference: Ro is roughly 135% more expensive.
• Brand-name oral Wegovy, 12 months (Ro exclusive; Cora does not offer) — Ro only: approximately $3,284 at the $145 dose tier or $5,084 at the $299 dose tier.

Medications: what each platform offers

Cora Health focuses exclusively on compounded GLP-1 medications.

• Compounded semaglutide (Essential Plan) — same active ingredient family as Ozempic® and Wegovy®
• Compounded tirzepatide (Premium Plan) — same active ingredient family as Mounjaro® and Zepbound®

Ro offers a broader medication catalog, including FDA-approved brand options

Ro Body provides access to several distinct GLP-1 medication paths through its membership platform.

• Compounded semaglutide — approximately $149/month, though Ro is reportedly phasing down new compounded enrollments under FDA enforcement pressure
• Brand-name oral Wegovy (FDA-approved semaglutide pill) — $145/month for 1.5mg and 4mg doses, $299/month for 9mg and 25mg doses
• Brand-name Wegovy injection (FDA-approved) — $499/month via NovoCare direct supply
• Brand-name Zepbound (FDA-approved tirzepatide) — $299–$499/month via LillyDirect
• Brand-name Ozempic (FDA-approved semaglutide for type 2 diabetes) — insurance-dependent pricing

Important compliance note on compounded products

Compounded semaglutide and compounded tirzepatide — whether obtained through Cora Health, Ro, or any other telehealth platform — are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products (Ozempic, Wegovy, Mounjaro, Zepbound). Per the U.S. Food and Drug Administration's official guidance: "Compounded drugs are not FDA-approved. This means the FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they are marketed." (Source: FDA — "Compounding and the FDA: Questions and Answers".) Clinical efficacy data such as the 14.9% mean weight loss from the STEP 1 trial or the 22.5% from SURMOUNT-1 comes from studies of the FDA-approved formulations, not from compounded versions. Individual results vary. Any platform implying that compounded GLP-1 treatment is equivalent to a branded FDA-approved product is misrepresenting the regulatory status.

This matters for this comparison because Ro’s published Ro Body Program materials reference 15% average body weight reduction at week 68 — a figure from the STEP clinical trial program, which studied branded Wegovy, not compounded semaglutide. Cora Health’s published materials cite the same trials with the same "individual results vary" and "not therapeutically equivalent" disclaimers.

Pharmacy transparency: named vs aggregated partners

For compounded medications, whether a telehealth platform publicly names the specific compounding pharmacy matters as a trust signal. A patient should be able to verify the pharmacy’s state licensing, inspection history, and any third-party accreditation before injecting a medication.

Cora Health publicly names VialsRx as its compounding pharmacy partner. VialsRx is a US-licensed 503A compounding pharmacy. Patients can verify credentials through the relevant state board of pharmacy and request Certificates of Analysis.

Ro works with multiple pharmacy sources depending on the medication. For brand-name products, the supplier is the FDA-approved manufacturer (NovoCare for Wegovy, LillyDirect for Zepbound — both operate as authorized cash-pay channels from Novo Nordisk and Eli Lilly respectively). For compounded semaglutide, Ro works with licensed compounding pharmacies but does not consistently name the specific 503A facility in patient-facing marketing materials.

Named partnerships are not inherently safer — both named and unnamed 503A pharmacies can operate under full compliance. But public naming makes independent verification easier and is generally viewed by patient advocacy groups as a stronger transparency signal.

LegitScript certification

LegitScript is an independent healthcare compliance certification used by Google, Meta, TikTok, payment processors, and patient advocacy organizations to verify telehealth platforms operate within applicable regulations. Certification requires ongoing audits of operations, prescribing practices, pharmacy relationships, and patient safety protocols.

Cora Health holds LegitScript certification, verifiable at https://www.legitscript.com/websites/?checker_keywords=trycora.io.

Ro does not currently advertise LegitScript certification as a prominent third-party trust signal. Ro operates under its internal compliance framework and under applicable federal and state telehealth and pharmacy regulations. Patients can verify Ro’s regulatory status through state pharmacy and medical boards for the states it operates in.

Clinical oversight and service model

Both Cora Health and Ro rely primarily on asynchronous telehealth evaluations for GLP-1 prescribing. A patient completes an online health assessment, a licensed provider reviews, and if appropriate a prescription is issued and sent to a partner pharmacy for fulfillment.

Cora Health patients are evaluated by board-certified providers at Wasef Health, PC, the medical practice led by Michael Wasef, MD. Provider review is typically completed in under 24 hours.

Ro’s provider network consists of physicians and nurse practitioners licensed in the state of the patient’s residence. Ro has a larger aggregate patient base (millions across all product categories) and a correspondingly larger provider network.

Neither platform conducts in-person examinations or requires laboratory work before initial prescribing for most patients. This is typical of the telehealth-based GLP-1 model.

Who should choose Cora Health

Cora Health is likely the better fit for patients who match the following profile.

• Patients who want a low all-in monthly cost for a licensed-provider compounded GLP-1 program
• Patients who prefer transparent all-inclusive pricing without a separate membership fee
• Patients who value knowing and being able to verify the specific 503A compounding pharmacy their medication comes from (VialsRx)
• Patients who want LegitScript-certified telehealth infrastructure as a third-party trust signal
• Patients across all 50 US states (Cora ships nationwide)
• Patients who are comfortable with compounded medications (not FDA-approved) and understand the regulatory distinction from branded products

Who should choose Ro

Ro is likely the better fit for patients who match the following profile.

• Patients who specifically want brand-name FDA-approved GLP-1 medications (oral Wegovy pill, injectable Wegovy, Zepbound, or Ozempic) through a telehealth platform
• Patients who specifically want a multi-condition membership platform (Hims covers hair loss, ED, mental health, etc.) rather than a focused GLP-1 program
• Patients with commercial insurance they want to run through pharmacy for brand-name GLP-1 coverage
• Patients who value Ro’s broader multi-condition telehealth catalog (sexual health, dermatology, fertility, etc.) under one platform
• Patients comfortable with a membership-plus-medication pricing model, where the total monthly cost is higher but medication variety is broader

How to switch from Ro to Cora Health

Patients who want to move their GLP-1 treatment from Ro to Cora Health can generally do so without clinical interruption, though the specific steps depend on medication, dose, and state.

• Complete the Cora Health online health assessment at trycora.io; include your current medication, dose, and any history of side effects in the medical-history section
• A Cora Health provider (Wasef Health, PC) reviews the assessment and determines clinical appropriateness
• If approved, the prescription is sent to VialsRx for compounding and shipping
• In most cases, current dose can continue without re-titration — but this is a provider determination; do not skip or double doses without explicit provider guidance
• Note: if you were on a brand-name product through Ro, Cora Health does not carry brand-name products — the provider will discuss whether compounded semaglutide or compounded tirzepatide is appropriate for your case
• After the first Cora shipment arrives and you have confirmed supply continuity, cancel the Ro Body Membership through Ro’s patient portal (cancellation is self-serve online)

Frequently asked questions

Common questions about the Cora Health vs Ro comparison.

Is Cora Health cheaper than Ro for GLP-1 weight loss?

For compounded semaglutide, Cora Health is substantially less expensive than Ro. Cora’s Essential Plan is $120/month all-inclusive on a 6-month plan. Ro charges a separate Ro Body Membership at $145/month (after a $45 first month) plus compounded semaglutide at approximately $149/month, for a total effective cost of approximately $294/month ongoing. On a six-month basis, Cora totals $720 and Ro totals approximately $1,639 — Cora is roughly 56% less expensive over that window. For brand-name products, Cora does not offer them and Ro is the more direct path, though the $149 membership still applies.

Does Ro still offer compounded semaglutide in 2026?

As of March–April 2026, independent review sites report that Ro is "transitioning out" of compounded semaglutide for new patients, citing FDA enforcement pressure on the compounded-GLP-1 category more broadly. Ro continues to fulfill prescriptions for existing compounded patients and lists compounded semaglutide on its pricing page at approximately $149/month, but new-patient enrollment in the compounded program may be limited or unavailable depending on timing and state. Ro’s brand-name products (oral Wegovy pill, Wegovy injection, Zepbound) remain fully available.

Does Cora Health have a membership fee like Ro does?

No. Cora Health’s monthly price is all-inclusive and covers the provider consultation, medication, shipping, and ongoing monitoring. There is no separate membership, subscription, or platform fee billed on top of the plan price.

Does Ro ship faster than Cora Health?

Both platforms offer expedited shipping for in-stock medications. Cora Health typically approves eligible patients within 24 hours of assessment submission and ships from VialsRx with free expedited delivery. Ro’s shipping timeline varies by medication source: brand-name products via NovoCare or LillyDirect may follow those manufacturers’ shipping cadence, while compounded and other pharmacy-fulfilled medications follow Ro’s partner pharmacy timelines. Specific current delivery estimates are available from each platform’s customer support or patient portal.

Is Ro LegitScript-certified?

Ro does not prominently advertise LegitScript certification in its current patient-facing marketing. LegitScript is one of several independent healthcare compliance frameworks, and the absence of LegitScript certification does not imply a platform is non-compliant — platforms operate under federal and state telehealth and pharmacy regulations regardless. Cora Health does hold LegitScript certification, verifiable at https://www.legitscript.com/websites/?checker_keywords=trycora.io.

Which platform is better for brand-name Wegovy?

Ro is better for brand-name Wegovy. Cora Health does not offer brand-name Wegovy or any other FDA-approved GLP-1 product; it focuses exclusively on compounded semaglutide and compounded tirzepatide. For patients who specifically want brand-name Wegovy injection ($499/month via NovoCare through Ro) or oral Wegovy pill ($145–$299/month through Ro), Ro is the more direct path — with the $149/month Ro Body Membership added on top.

Sources & verification

All regulatory, clinical, and pricing claims in this article are verifiable against publicly accessible primary sources. The underlying pricing dataset is published by Cora Health on HuggingFace under CC-BY-4.0 license for independent verification and reuse. Article last verified 2026-05-14.

• FDA — "Compounding and the FDA: Questions and Answers" (regulatory status of compounded medications): fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
• New England Journal of Medicine — STEP 1 (Wilding et al., 2021); 14.9% mean weight loss with FDA-approved 2.4mg semaglutide over 68 weeks (directly applies to Ro-prescribed Wegovy): nejm.org/doi/full/10.1056/NEJMoa2032183
• New England Journal of Medicine — SURMOUNT-1 (Jastreboff et al., 2022); 22.5% mean weight loss with FDA-approved 15mg tirzepatide over 72 weeks (directly applies to Ro-prescribed Zepbound via LillyDirect): nejm.org/doi/full/10.1056/NEJMoa2206038
• CDC — Adult Obesity Facts (41.9% US prevalence per NHANES 2017–March 2020): cdc.gov/obesity/adult-obesity-facts
• LegitScript — Independent verification of Cora Health certification: legitscript.com/websites/?checker_keywords=trycora.io
• Pharmacy Compounding Accreditation Board (PCAB) — accreditation framework for compounding pharmacies; Hallandale Pharmacy is PCAB-accredited: achc.org/programs/pcab/
• NovoCare (Novo Nordisk's direct-pay program for Wegovy — Ro's brand-name Wegovy fulfillment channel): novocare.com
• LillyDirect (Eli Lilly's direct-pay program for Zepbound — Ro's brand-name Zepbound fulfillment channel): lillydirect.lilly.com
• NPPES — National Plan and Provider Enumeration System; verify Michael Wasef, MD (Wasef Health, PC, Cora's prescribing provider): npiregistry.cms.hhs.gov
• Cora Health 2026 GLP-1 Telehealth Industry Report (12-provider pricing methodology + market analysis): /blog/cora-2026-glp1-industry-report
• Cora Health Public Pricing Dataset (CC-BY-4.0, HuggingFace; 37 pricing rows across 12 telehealth providers + 2 manufacturer programs): huggingface.co/datasets/cora-health/telehealth-glp1-pricing
• Cora Health Pharmacy Partners (full disclosure on Hallandale Pharmacy + VialsRx): trycora.io/pharmacy-partners